Balance Sheet

Cash Flow Statement

Amortization Amortization Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Cost of Revenue Depreciation & Amortization (IS)EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding

BioNTech SE (BNTX) Shares Repurchased (2022 - 2023)

BioNTech SE's Shares Repurchased history spans 2 years, with the latest figure at -$860751.9 for Q4 2023.

On a quarterly basis, Shares Repurchased changed N/A to -$860751.9 in Q4 2023 year-over-year; TTM through Dec 2023 was -$799.7 million, a N/A change, with the full-year FY2023 number at -$794.6 million, changed N/A from a year prior.
Shares Repurchased hit -$860751.9 in Q4 2023 for BioNTech SE, up from -$328.4 million in the prior quarter.
Over the last five years, Shares Repurchased for BNTX hit a ceiling of -$860751.9 in Q4 2023 and a floor of -$649.1 million in Q3 2022.